ID

24607

Descripción

Study ID: 100470 Clinical Study ID: SCO100470 Study Title: A multicentre, randomised, double-blind, parallel group, 24 week study to compare the effect of salmeterol/fluticasone propionate combination product 50/250mcg, with salmeterol 50mcg both delivered twice daily via DISKUS®/ACCUHALER® inhaler on lung function and dyspnoea in subjects with Chronic Obstructive Pulmonary Disease (COPD). Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor:GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: fluticasone propionate/salmeterol Trade Name: Serevent Study Indication: Pulmonary Disease, Chronic Obstructive

Palabras clave

Versiones (3)
  1. 6/8/17 6/8/17 -
  2. 8/8/17 8/8/17 -
  3. 8/8/17 8/8/17 -
Subido en

8 de agosto de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

  • El más nuevo
  • Más antiguo
  • Popular
  • El más nuevo
    • El más nuevo
    • Más antiguo
    • Popular

Sin comentarios

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

concomitant medication salmeterol/fluticasone propionate combination compared to salmeterol on COPD 100470

Inglés

concomitant medication salmeterol/fluticasone propionate combination compared to salmeterol on COPD 100470

1 formularios  
Administrative Data
Descripción

Administrative Data

Alias
UMLS CUI-1
C1320722
Subject Identifier
Descripción

subject identifier

Tipo de datos

integer

Alias
UMLS CUI [1]
C2348585
COPD CONCOMITANT MEDICATIONS
Descripción

COPD CONCOMITANT MEDICATIONS

Alias
UMLS CUI-1
C2347852
UMLS CUI-2
C0024117
Were any COPD concomitant medications taken by the subject prior to screening and/or during the study?
Descripción

COPD concomitant medication

Tipo de datos

text

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C0024117
If "yes" to COPD concomitant medication, record each medication separately by fulfilling the following items.
Descripción

If "yes" to COPD concomitant medication, record each medication separately by fulfilling the following items.

Alias
UMLS CUI-1
C2347852
UMLS CUI-2
C0024117
Drug Name
Descripción

Trade name preferred.

Tipo de datos

text

Alias
UMLS CUI [1]
C2360065
Unit Dose
Descripción

unit dose

Tipo de datos

integer

Alias
UMLS CUI [1]
C0869039
Unit
Descripción

units of medication

Tipo de datos

text

Alias
UMLS CUI [1]
C1519795
Frequency
Descripción

frequency of medication

Tipo de datos

text

Alias
UMLS CUI [1]
C3476109
Route
Descripción

medication routes

Tipo de datos

text

Alias
UMLS CUI [1]
C0013153
Start Date
Descripción

start date of medication

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0808070
Taken prior to study?
Descripción

medication taken prior to study

Tipo de datos

text

Alias
UMLS CUI [1]
C2826667
Stop Date
Descripción

stop date of medication

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0806020
Ongoing medication?
Descripción

concomitant medication ongoing

Tipo de datos

text

Alias
UMLS CUI [1]
C2826666
Was drug administered for an exacerbation?
Descripción

drug adminstered for a COPD exacerbation

Tipo de datos

text

Alias
UMLS CUI [1,1]
C3469597
UMLS CUI [1,2]
C0740304
NON-COPD CONCOMITANT MEDICATIONS
Descripción

NON-COPD CONCOMITANT MEDICATIONS

Alias
UMLS CUI-1
C2347852
Were any concomitant medications taken by the subject prior to screening and/or during the study?
Descripción

medication that is not COPD-related

Tipo de datos

text

Alias
UMLS CUI [1]
C2347852
If "yes" to non-COPD concomitant medication, record each medication separately by fulfilling the following items.
Descripción

If "yes" to non-COPD concomitant medication, record each medication separately by fulfilling the following items.

Alias
UMLS CUI-1
C2347852
Drug name
Descripción

Trade name preferred.

Tipo de datos

text

Alias
UMLS CUI [1]
C2360065
Unit Dose
Descripción

unit dose

Tipo de datos

integer

Alias
UMLS CUI [1]
C0869039
Unit
Descripción

units of medication

Tipo de datos

text

Alias
UMLS CUI [1]
C1519795
Frequency
Descripción

frequency of medication

Tipo de datos

text

Alias
UMLS CUI [1]
C3476109
Route
Descripción

medication routes

Tipo de datos

text

Alias
UMLS CUI [1]
C0013153
Reason for Medication
Descripción

reason for medication

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0392360
UMLS CUI [1,2]
C0013227
Start Date
Descripción

start date of medication

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0808070
Taken prior to study?
Descripción

medication taken prior to study

Tipo de datos

text

Alias
UMLS CUI [1]
C2826667
Stop Date
Descripción

stop date of medication

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0806020
Ongoing medication?
Descripción

concomitant medication ongoing

Tipo de datos

text

Alias
UMLS CUI [1]
C2826666
Volver a la parte superior de la página

Similar models

concomitant medication salmeterol/fluticasone propionate combination compared to salmeterol on COPD 100470

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Administrative Data
C1320722 (UMLS CUI-1)
subject identifier
Item
Subject Identifier
integer
C2348585 (UMLS CUI [1])
Item Group
COPD CONCOMITANT MEDICATIONS
C2347852 (UMLS CUI-1)
C0024117 (UMLS CUI-2)
Item
Were any COPD concomitant medications taken by the subject prior to screening and/or during the study?
text
C2347852 (UMLS CUI [1,1])
C0024117 (UMLS CUI [1,2])
COPD concomitant medication
Code List
Were any COPD concomitant medications taken by the subject prior to screening and/or during the study?
CL Item
Yes (Y)
CL Item
No (N)
Item Group
If "yes" to COPD concomitant medication, record each medication separately by fulfilling the following items.
C2347852 (UMLS CUI-1)
C0024117 (UMLS CUI-2)
medication name
Item
Drug Name
text
C2360065 (UMLS CUI [1])
unit dose
Item
Unit Dose
integer
C0869039 (UMLS CUI [1])
Item
Unit
text
C1519795 (UMLS CUI [1])
units of medication
Code List
Unit
CL Item
Actuation (ACTU)
CL Item
Ampoule  (AMP)
CL Item
Application  (APP)
CL Item
Bottle  (BOT)
CL Item
Cubic centimeter (CC)
CL Item
Capsule (CAP)
CL Item
Gram (G)
CL Item
Drops  (GTT)
CL Item
International Units (IU)
CL Item
Litre (L)
CL Item
Litres per minute (L/MIN)
CL Item
Lozenge (LOZ)
CL Item
Microgram (MCG)
CL Item
Microgram per kilogram per minute (MCG/KG/MIN)
CL Item
Microlitre (MCL)
CL Item
Millimole (MMOL)
CL Item
Nebule (NEB)
CL Item
Puff (PUFF)
CL Item
Spray (SPR)
CL Item
Tablet (TAB)
CL Item
Tablespoon (TBLSP)
CL Item
Teaspoon (TSP)
CL Item
Percent (%)
CL Item
Unknown (UNK)
Item
Frequency
text
C3476109 (UMLS CUI [1])
frequency of medication
Code List
Frequency
CL Item
1 X daily (OD/QD)
CL Item
2 X daily (BID)
CL Item
3 X daily (TID)
CL Item
4 X daily  (QID)
CL Item
Continuous (CONT)
CL Item
Cumulative dose (CUM)
CL Item
Daily (D)
CL Item
Intermittent (INT)
CL Item
Not available (NA)
CL Item
At night (NOCT)
CL Item
Other (OTH)
CL Item
As required (PRN)
CL Item
Every hour (quaque hora) (QH)
CL Item
Every other day (QOD)
CL Item
Every night (quaque nocte) (QN)
CL Item
Single dose (SD)
CL Item
Immediately (STAT)
CL Item
Taper (TAP)
CL Item
Unknown (UNK)
Item
Route
text
C0013153 (UMLS CUI [1])
medication routes
Code List
Route
CL Item
Intramuscular (IM)
CL Item
Inhalation (IH)
CL Item
Intranasal (IN)
CL Item
Injection (INJ)
CL Item
Intravenous (IV)
CL Item
Nasal (NS)
CL Item
Other (OTH)
CL Item
Oral (PO)
CL Item
Subcutaneous (SC)
CL Item
Topical (TP)
CL Item
Unknown (UNK)
start date of medication
Item
Start Date
date
C0013227 (UMLS CUI [1,1])
C0808070 (UMLS CUI [1,2])
Item
Taken prior to study?
text
C2826667 (UMLS CUI [1])
medication taken prior to study
Code List
Taken prior to study?
CL Item
Yes (Y)
CL Item
No (N)
stop date of medication
Item
Stop Date
date
C0013227 (UMLS CUI [1,1])
C0806020 (UMLS CUI [1,2])
Item
Ongoing medication?
text
C2826666 (UMLS CUI [1])
concomitant medication ongoing
Code List
Ongoing medication?
CL Item
Yes (Y)
CL Item
No (N)
Item
Was drug administered for an exacerbation?
text
C3469597 (UMLS CUI [1,1])
C0740304 (UMLS CUI [1,2])
drug adminstered for a COPD exacerbation
Code List
Was drug administered for an exacerbation?
CL Item
Yes (Y)
CL Item
No (N)
Item Group
NON-COPD CONCOMITANT MEDICATIONS
C2347852 (UMLS CUI-1)
Item
Were any concomitant medications taken by the subject prior to screening and/or during the study?
text
C2347852 (UMLS CUI [1])
concomitant medication
Code List
Were any concomitant medications taken by the subject prior to screening and/or during the study?
CL Item
Yes (Y)
CL Item
No (N)
Item Group
If "yes" to non-COPD concomitant medication, record each medication separately by fulfilling the following items.
C2347852 (UMLS CUI-1)
medication name
Item
Drug name
text
C2360065 (UMLS CUI [1])
unit dose
Item
Unit Dose
integer
C0869039 (UMLS CUI [1])
Item
Unit
text
C1519795 (UMLS CUI [1])
units of medication
Code List
Unit
CL Item
Actuation (ACTU)
CL Item
Ampoule  (AMP)
CL Item
Application  (APP)
CL Item
Bottle  (BOT)
CL Item
Cubic centimeter (CC)
CL Item
Capsule (CAP)
CL Item
Gram (G)
CL Item
Drops  (GTT)
CL Item
International Units (IU)
CL Item
Litre (L)
CL Item
Litres per minute (L/MIN)
CL Item
Lozenge (LOZ)
CL Item
Microgram (MCG)
CL Item
Microgram per kilogram per minute (MCG/KG/MIN)
CL Item
Microlitre (MCL)
CL Item
Millimole (MMOL)
CL Item
Nebule (NEB)
CL Item
Puff (PUFF)
CL Item
Spray (SPR)
CL Item
Tablet (TAB)
CL Item
Tablespoon (TBLSP)
CL Item
Teaspoon (TSP)
CL Item
Percent (%)
CL Item
Unknown (UNK)
Item
Frequency
text
C3476109 (UMLS CUI [1])
frequency of medication
Code List
Frequency
CL Item
1 X daily (OD/QD)
CL Item
2 X daily (BID)
CL Item
3 X daily (TID)
CL Item
4 X daily  (QID)
CL Item
Continuous (CONT)
CL Item
Cumulative dose (CUM)
CL Item
Daily (D)
CL Item
Intermittent (INT)
CL Item
Not available (NA)
CL Item
At night (NOCT)
CL Item
Other (OTH)
CL Item
As required (PRN)
CL Item
Every hour (quaque hora) (QH)
CL Item
Every other day (QOD)
CL Item
Every night (quaque nocte) (QN)
CL Item
Single dose (SD)
CL Item
Immediately (STAT)
CL Item
Taper (TAP)
CL Item
Unknown (UNK)
Item
Route
text
C0013153 (UMLS CUI [1])
medication routes
Code List
Route
CL Item
Intramuscular (IM)
CL Item
Inhalation (IH)
CL Item
Intranasal (IN)
CL Item
Injection (INJ)
CL Item
Intravenous (IV)
CL Item
Nasal (NS)
CL Item
Other (OTH)
CL Item
Oral (PO)
CL Item
Subcutaneous (SC)
CL Item
Topical (TP)
CL Item
Unknown (UNK)
reason for medication
Item
Reason for Medication
text
C0392360 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
start date of medication
Item
Start Date
date
C0013227 (UMLS CUI [1,1])
C0808070 (UMLS CUI [1,2])
Item
Taken prior to study?
text
C2826667 (UMLS CUI [1])
medication taken prior to study
Code List
Taken prior to study?
CL Item
Yes (Y)
CL Item
No (N)
stop date of medication
Item
Stop Date
date
C0013227 (UMLS CUI [1,1])
C0806020 (UMLS CUI [1,2])
Item
Ongoing medication?
text
C2826666 (UMLS CUI [1])
concomitant medication ongoing
Code List
Ongoing medication?
CL Item
Yes (Y)
CL Item
No (N)
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial